COPENHAGEN, Feb 2 (Reuters) - Danish vaccine maker Bavarian Nordic (BAVA.CO: Quote, Profile , Research) on Friday said it agreed with GlaxoSmithKline (GSK.L: Quote, Profile , Research) to end their collaboration for the production and marketing of IMVAMUNE, a third-generation smallpox vaccine under development.
